www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

USEUROPEAFRICAASIA 中文雙語Fran?ais
China
Home / China / National affairs

Guideline speeds access to drugs

By Wang Xiaodong | China Daily | Updated: 2017-10-10 07:31

Drugs developed in other countries are expected to be available for use on the Chinese mainland more quickly under a new guideline released by the central government.

Authorities in China will now accept data collected from clinical trials conducted outside the mainland for applications to register drugs and medical equipment, according to the guideline on reforming approval procedures, which was released by the State Council on Sunday.

The data must be collected from clinical trials conducted at more than one center and must meet Chinese regulations for registration of drugs and medical equipment, the guideline said.

"The purpose of the measure is to reduce the time needed for approval of drugs from overseas," Wu Zhen, vice-minister of the China Food and Drug Administration, said on Monday.

China's current drug evaluation and approval system needs improving to expedite the use of new drugs in China, Wu said.

Under current regulations, food and drug authorities cannot accept clinical trial data collected from overseas, and new drugs being developed overseas should finish their first phase of clinical trials overseas before developers can apply to start clinical trials on the mainland, he said.

Guideline speeds access to drugs

This has delayed the availability of some major drugs on the Chinese market, he said.

Of 433 drugs approved for sale in developed countries between 2001 and last year, only 30 percent are available on the Chinese mainland.

Over the past 10 years, patients on the mainland have had to wait five to seven years longer for some major new drugs than patients in Europe and the United States, he said.

"This has caused an increasing number of people to buy drugs through the internet and from overseas, which has many potential risks," he said.

"Recognizing data collected from overseas can reduce unnecessary trials, which reduces the cost of drug research and development and improves Chinese patients' access to drugs," said Wang Lifeng, chief of product registration for drugs and cosmetics at the CFDA.

The CFDA will make more detailed regulations to better carry out the guideline, he said.

Meanwhile, the administration will intensify its supervision and inspection of clinical trials conducted overseas, and send inspectors to clinical trial centers overseas for site inspection to ensure that the data collected are accurate, Wang said.

The guideline also bans medical representatives from selling drugs and will hold them accountable if they have done so.

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 亚洲女人在线 | 在线观看免费亚洲 | 欧美三级香港三级日本三级 | 国产玖玖在线观看 | 99久久亚洲 | 国产人妖xxxx做受视频 | 男女超猛烈啪啦啦的免费视频 | 亚洲欧美字幕 | 大学生久久香蕉国产线观看 | 亚洲国产欧美日韩第一香蕉 | 国产亚洲高清不卡在线观看 | 国产在线乱子伦一区二区 | 免费aⅴ在线 | 久久久久欧美精品观看 | 91丨九色丨首页在线观看 | 在线日本视频 | 99re热精品视频国产免费 | 免费国产黄 | 久久国产成人精品国产成人亚洲 | 国产成人亚洲精品影院 | 亚洲综合日韩欧美一区二区三 | 国产特黄一级一片免费 | 欧美aaaa在线观看视频免费 | 国产一久久香蕉国产线看观看 | 国产午夜三级 | 日韩精品免费一级视频 | 中文字幕在线无限2021 | 成年人免费在线视频观看 | 国产在线不卡视频 | 国产日比视频 | 中国一级做a爰片久久毛片 中日韩欧美一级毛片 | 久久久久久久久久久久久久久久久久 | 国产一级毛片夜一级毛片 | 国产成人99久久亚洲综合精品 | 成人看片黄a在线观看 | 一区二区网站在线观看 | 午夜精品一区二区三区在线观看 | 国产成人免费视频精品一区二区 | 久久久久久久岛国免费观看 | 欧美日韩精品一区二区三区不卡 | 96精品视频在线播放免费观看 |